Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study

被引:26
|
作者
Chung, Seokang [1 ]
Park, Sue K. [1 ,2 ,3 ]
Sung, Hyuna [1 ]
Song, Nan [2 ]
Han, Wonshik [2 ,4 ]
Noh, Dong-Young [2 ,4 ]
Ahn, Sei-Hyun [5 ,6 ]
Yoo, Keun-Young [3 ]
Choi, Ji-Yeob [1 ,2 ]
Kang, Daehee [1 ,2 ,3 ]
机构
[1] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 110799, South Korea
[2] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110799, South Korea
[5] Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea
[6] ASAN Med Ctr, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Breast cancer; Hormone receptor status; Chronological change; Reproductive factors; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; AGE; ETHNICITY; CARCINOMA; IMPACT; POLYMORPHISMS; PREVENTION; DIAGNOSIS;
D O I
10.1007/s10549-013-2645-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lifestyle factors have been chronologically changed into western style ones, which could result in the rapid increase of breast cancer incidence in Korea. It is plausible that reproductive factors through hormonal mechanisms are differentially related to the risk of breast cancer subtypes. We investigated the association of reproductive risk factors on breast cancer by birth year groups and also evaluated the differential associations on the hormone receptor-defined subtypes. Using the data from the Seoul Breast Cancer Study (SeBCS), a multicenter case-control study, 3,332 breast cancer patients and 3,620 control subjects were analyzed. The distribution of subtypes among cases was as follows: 61.0 % estrogen receptor (ER)-positive, 51.9 % progesterone receptor (PR)-positive, and 43.4 % both ER/PR-positive status, respectively. Polytomous logistic regression and Wald tests for heterogeneity have been used across the subtypes. The frequencies of reproductive-related risk factors including early age at menarche, nulligravid, age at first full-term pregnancy (FFTP), duration of estrogen exposure before FFTP (EEBF), less number of children, never breastfeeding, and short duration of breastfeeding has increased as women were born later in both cases and controls, respectively (p (trend) < 0.0001. Among breast cancer patients, either ER- or PR-positive subtypes were increased in women born in 1960s compared to women born in 1940s. Early age at menarche increased the risk of breast cancer regardless of the subtypes while nulligravid, late age at FFTP, and longer duration of EEBP were associated with hormone receptor-positive cancer risk only (p (heterogeneity) < 0.05), which associations were stronger among women born later. Our results suggest that the associations of age at menarche, parity, age at FFTP, and duration of EEBF with breast cancer risk were different based on the hormone receptor status and birth year groups in Korea.
引用
收藏
页码:557 / 565
页数:9
相关论文
共 50 条
  • [21] Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
    Bao, Ping-Ping
    Shu, Xiao Ou
    Gao, Yu-Tang
    Zheng, Ying
    Cai, Hui
    Deming, Sandra L.
    Ruan, Zhi-Xian
    Su, Yinghao
    Gu, Kai
    Lu, Wei
    Zheng, Wei
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (06) : 661 - 671
  • [22] SSRI use and breast cancer risk by hormone receptor status
    Patricia F. Coogan
    Brian L. Strom
    Lynn Rosenberg
    Breast Cancer Research and Treatment, 2008, 109 : 527 - 531
  • [23] SSRI use and breast cancer risk by hormone receptor status
    Coogan, Patricia F.
    Strom, Brian L.
    Rosenberg, Lynn
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 527 - 531
  • [24] Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status
    Tutera, AM
    Sellers, TA
    Potter, JD
    Drinkard, CR
    Wiesner, GL
    Folsom, AR
    GENETIC EPIDEMIOLOGY, 1996, 13 (02) : 207 - 221
  • [25] Associations of Hormone-Related Factors With Breast Cancer Risk According to Hormone Receptor Status Among White and African American Women
    Cui, Yong
    Deming-Halverson, Sandra L.
    Shrubsole, Martha J.
    Beeghly-Fadiel, Alicia
    Fair, Alecia M.
    Sanderson, Maureen
    Shu, Xiao-Ou
    Kelley, Mark C.
    Zheng, Wei
    CLINICAL BREAST CANCER, 2014, 14 (06) : 417 - 425
  • [26] Effects of Reproductive Factors on Risk of Breast Cancer: A Literature Review
    Parsa, Parisa
    Parsa, Bita
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (04) : 545 - 550
  • [27] Socioeconomic disparities and breast cancer hormone receptor status
    Andaya, Abegail A.
    Enewold, Lindsey
    Horner, Marie-Josephe
    Jatoi, Ismail
    Shriver, Craig D.
    Zhu, Kangmin
    CANCER CAUSES & CONTROL, 2012, 23 (06) : 951 - 958
  • [28] Association between obstetric factors, hormone levels and nutritional status with the development of breast cancer
    Gonzalez-Jimenez, Emilio
    Angel Montero-Alonso, Miguel
    Schmidt Riovalle, Jacqueline
    REVISTA MEDICA DE CHILE, 2013, 141 (12) : 1541 - 1546
  • [29] Dietary Mushroom Intake and the Risk of Breast Cancer Based on Hormone Receptor Status
    Shin, Aesun
    Kim, Jeongseon
    Lim, Sun-Young
    Kim, Gaeul
    Sung, Mi-Kyung
    Lee, Eun-Sook
    Ro, Jungsil
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (04): : 476 - 483
  • [30] Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer
    Wunderle, Marius
    Pretscher, Jutta
    Brucker, Sara Y.
    Volz, Bernhard
    Hartmann, Arndt
    Fiessler, Cornelia
    Hein, Alexander
    Haeberle, Lothar
    Jud, Sebastian M.
    Lux, Michael P.
    Janni, Wolfgang
    Loehberg, Christian R.
    Hartkopf, Andreas D.
    Walter, Christina B.
    Baake, Gerold
    Fridman, Alexander
    Malter, Wolfram
    Wuerstlein, Rachel
    Harbeck, Nadia
    Hoffmann, Oliver
    Kuemmel, Sherko
    Martin, Bernhard
    Thomssen, Christoph
    Graf, Heiko
    Wolf, Christopher
    Bayer, Christian M.
    Hack, Carolin C.
    Almstedt, Katrin
    Gass, Paul
    Heindl, Felix
    Brodkorb, Tobias F.
    Nabieva, Naiba
    Lindner, Christoph
    Kolberg, Hans-Christian
    Krabisch, Petra
    Weigel, Michael
    Steinfeld-Birg, Dieter
    Kohls, Andreas
    Brucker, Cosima
    Schulz, Volker
    Fischer, Gunnar
    Pelzer, Volker
    Wallwiener, Diethelm
    Rack, Brigitte
    Fehm, Tanja
    Rody, Achim
    Maass, Nicolai
    Beckmann, Matthias W.
    Fasching, Peter A.
    Rauh, Claudia
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 453 - 461